RIPPLE XRP PRICE PREDICTION 2025
1 extracted signal · 1 resolved · 0 still active
Cilinix Crypto12 Sept 2025, 13:44 UTC
AI-generated source summary
The video analyzes XRPUSDT, noting it broke a key level at $3.02. The analyst initially anticipated a potential retest of $2.92-$2.94 before the breakout but it didn't occur. He expected a move to $3.12. There's a lot of leverage piling into the price. The analyst advises caution due to potential for a price correction, it's possible to spike down into imbalances, with one specifically at $2.85. The analyst states If longing XRP with leverage with take profit at the top of the range, $3.28 , it would be sensible to place stop-loss orders under the fair value gap. The most important level to consider at the time of recording is the previous month's point of control. If BlackRock put in an application for a Ripple ETF, price targets are the top of the range, $3.28 and $3.3. Breaking above $3.28 is going to be tough.
AI-generated summary based on the source content.
Evidence and evaluation progress
- Original source published
The analyst published the original source item.
- First prediction resolved
The first evaluable outcome in this case reached a terminal result.
- Case evaluation completed
All evaluable predictions in this case reached terminal outcomes.
- Source recorded by Tahlil Plus
The public source was preserved as the evidence record for this case.
- Market predictions extracted
1 eligible signal linked to this case.
- Outcome tracking started
Tahlil Plus began monitoring the extracted predictions.
Signals in this source
More Prediction Case Files from Cilinix Crypto
BREAKDOWN UPDATE: WILL CRYPTO CRASH LOWER?🚨
DON'T MISS THIS MAJOR BULLISH SIGNAL!🔥 (Polkadot Update)
HEDERA PRICE PREDICTION FOR AUGUST! (HBAR Update)
SOLANA BREAKDOWN WARNING NOW!🚨 (SOL Update)
I AM WAITING FOR THIS ETHEREUM MOVE! (ETH Update)
CRITICAL MOMENT FOR XRP! (Breakdown Risk)
Cilinix Crypto
Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.
